Podcast Episodes
Back to SearchISA 2022: meeting highlights and recent updates in amyloidosis
Episode 161
The 18th Meeting of the International Society of Amyloidosis (ISA) was held in Heidelberg, Germany, on 4-8 September, 2022. This meeting brought toge…
3 years, 11 months ago
Highlights from IMS 2022: managing high-risk & frail patients with myeloma and the prognostic value of MRD
The 19th International Myeloma Society (IMS) Annual Meeting was held in Los Angeles, CA, and brought together experts in the field, who discussed sev…
3 years, 11 months ago
Highlights from IMS 2022: managing high-risk & frail patients with myeloma and the prognostic value of MRD
Episode 160
The 19th International Myeloma Society (IMS) Annual Meeting was held in Los Angeles, CA, and brought together experts in the field, who discussed sev…
3 years, 11 months ago
Highlights from the 2022 Texas MPN Workshop: early intervention, disease progression & future targets
The 2022 Texas MPN Workshop was held in San Antonio, TX, and covered several fascinating topics in the field of myeloproliferative neoplasms (MPNs). …
3 years, 11 months ago
Highlights from the 2022 Texas MPN Workshop: early intervention, disease progression & future targets
Episode 159
The 2022 Texas MPN Workshop was held in San Antonio, TX, and covered several fascinating topics in the field of myeloproliferative neoplasms (MPNs). …
3 years, 11 months ago
iwMDS 2022: Key highlights
The 1st International Workshop on Myelodysplastic Syndromes (iwMDS) 2022 was held in Miami, FL, and brought together leading experts in MDS who discu…
4 years ago
iwMDS 2022: Key highlights
Episode 158
The 1st International Workshop on Myelodysplastic Syndromes (iwMDS) 2022 was held in Miami, FL, and brought together leading experts in MDS who discu…
4 years ago
Identifying high-risk myeloma and improving treatment strategies in these patients
Multiple myeloma is a heterogeneous disease, and despite recent advances in therapeutic agents, several patients still relapse after therapy and have…
4 years ago
Identifying high-risk myeloma and improving treatment strategies in these patients
Episode 157
Multiple myeloma is a heterogeneous disease, and despite recent advances in therapeutic agents, several patients still relapse after therapy and have…
4 years ago
Improving the efficiency of drug approvals in MDS
In recent years, the treatment and management of myelodysplastic syndromes (MDS) has improved, and several clinical trials are investigating novel co…
4 years ago